3,4-dihydroxyphenylglycol has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrebola, MM; Bermúdez-Oria, A; De La Cruz, JP; Fernández-Prior, MÁ; González-Correa, JA; Martín-Aurioles, E; Ortega-Hombrados, L; Rodriguez-Pérez, MD; Santiago-Corral, L; Verdugo, C | 1 |
| Abdel-Sayed, M; al-Adli, N; Baker, H; Patel, J; Regan, T; Torres, R | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylglycol and Alloxan Diabetes
| Article | Year |
|---|---|
The Effect of the Extra Virgin Olive Oil Minor Phenolic Compound 3',4'-Dihydroxyphenylglycol in Experimental Diabetic Kidney Disease.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Olive Oil; Oxidative Stress; Phenols; Prostaglandins I; Rats | 2023 |
Influence of dietary myoinositol on myocardial vulnerability and norepinephrine release in a diabetic animal model.
Topics: Animals; Cardiac Pacing, Artificial; Diabetes Mellitus, Experimental; Diet; Dogs; Inositol; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Ventricular Fibrillation | 1993 |